Skip to main content

 Scientific publications

Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.

Authors : Martinez Chanza N, Bernard B, Barthelemy P, Accarain A, Paesmans M, Desmyter L, Tkint de Roodenbeke D, Gil T, Sideris S, Roumeguere T, Hamid AA, Sweeney CJ
Year : 2021
Journal : Prostate Cancer Prostatic Dis

Management of early breast cancer in patients bearing germline BRCA mutations.

Authors : Tkint de Roodenbeke D, Pondé N, Buisseret L, Piccart-Gebhart M
Year : 2020
Journal : Semin Oncol
Volume : 47
Pages : 243-248

BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.

Authors : Solinas C, Marcoux D, Garaud S, Vitória JR, Van den Eynden G, de Wind A, De Silva P, Boisson A, Craciun L, Larsimont D, Piccart-Gebhart M, Detours V, Tkint de Roodenbeke D, Willard-Gallo K
Year : 2019
Journal : Cancer Lett
Volume : 450
Pages : 88-97

Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.

Authors : Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim HA Jr, Desir J, Delbaere A, Tkint de Roodenbeke D, de Azambuja E, Ignatiadis M, Demeestere I
Year : 2018
Journal : Ann Oncol
Volume : 29(1)
Pages : 237-243

Soins Intensifs Oncologiques : revue des années 2013 et 2014

Authors : Sculier JP, Bucalau AM, Closset J, Compagnie M, Gorham J, Sideris S, Tkint de Roodenbeke D, Wang X, Berghmans T, Meert AP
Year : 2016
Journal : Rev Med Brux
Volume : 37(3
Pages : 159-67

Belgian Society of Medical oncology (BSMO - task force on breast cancer survivorship)

Authors : de Azambuja E, Azim HA, Buisseret L, Langenaeken C, Tkint de Roodenbeke D
Year : 2014
Journal : Belgian J Medical Oncology
Volume : 7(5)
Pages : 142-155